The blood that remains in your baby’s placenta and umbilical cord after birth is a rich, accessible and non-controversial source of haematopoietic stem cells (HSCs): extraordinary cells that can differentiate to become any type of blood cell.
HSCs can regenerate to replace any damaged blood cell in the human body, giving them the unique ability to treat diseases of the blood and immune systems.
HSCs like those in your baby’s cord blood have been used for over 30 years to treat a wide range of conditions affecting the blood and immune systems. Today, these include:
- Blood Cancers, such as Leukaemia, Lymphoma and Myeloma
- Blood Disorders, such as Sickle Cell Disease, Aplastic Anaemia and Fanconi Anaemia
- Immune Disorders such as, SCID and Wiskott-Aldrich Syndrome
- Metabolic Disorders such as Krabbe Disease and Hurler Syndrome
- Solid Tumours such as Neuroblastoma
Research suggests that mesenchymal stem cells like those found in cord tissue will soon be used to repair and replace damaged tissues and organs.
Scientists are currently investigating treatments for:
Spinal Cord Injury
Never content to rest on yesterday’s research, Biovault’s scientists are active contributors to tomorrow’s treatments. Following the award of a prestigious Industrial Fellowship by the Royal Commission for the Exhibition of 1851, our lead scientist Shaun Mansfield is working with University College London to increase the yield of stem cells from umbilical cord blood to improve the treatment of blood cancers.
Backed by science
Built for you by parents and pioneers